Effectiveness of bandage contact lens application in corneal epithelialization and pain alleviation following corneal transplantation; prospective, randomized clinical trial by unknown
RESEARCH ARTICLE Open Access
Effectiveness of bandage contact lens
application in corneal epithelialization
and pain alleviation following corneal
transplantation; prospective, randomized
clinical trial
Jun Shimazaki*, Chika Shigeyasu, Yumiko Saijo-Ban, Murat Dogru and Seika Den
Abstract
Background: To assess the efficacy of bandage contact lens (BCL) application to promote epithelialization and
alleviate pain following corneal transplantation.
Methods: Twenty-six consecutive patients who underwent corneal transplantation were randomly assigned to
undergo BCL application (BCL group, n = 14) or no BCL application (control group, n = 12) at the end of the
surgery. Corneal epithelialization was analyzed by photography using fluorescein staining, and ocular pain was
measured using a visual analog scale.
Results: The mean size of the epithelial defect relative to the graft area in the BCL group was 21.80 ± 35.10 % at
the end of surgery, 18.20 ± 31.10 % on postoperative day 1, and 5.45 ± 11.10 % on postoperative days 3 to 5. These
values in the control group were 9.64 ± 17.60 % at the end of surgery, 11.50 ± 25.70 % on postoperative day 1, and
0.00 ± 0.00 % on postoperative days 3 to 5. There were no significant differences in the speed of epithelialization
between the two groups. The mean preoperative pain score in the BCL group was slightly higher than that control
(4.27 ± 1.96 vs. 2.41 ± 2.18, respectively; P = 0.039). The scores significantly increased on postoperative day 1 and
promptly returned to preoperative levels by day 7 in both groups, and there were no significant differences
between the groups.
Conclusions: No significant benefits of BCL application at the time of corneal transplantation were observed in this
study. The efficacy and safety of BCLs in eyes with compromised epithelialization require further study.
Trial registration number: UMIN 000019091. Date of registration: 2015/09/22
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Background
Proper postoperative management is a key factor for
successful outcomes of corneal transplantation. In par-
ticular, prompt epithelialization is essential for avoiding
vision-threatening complications such as infection, scar-
ring, and stromal melting [1]. Application of a bandage
contact lens (BCL) is one management technique for
promoting corneal epithelialization. The use of a BCL
was first reported by Gasset and Kaufman in 1970 [2],
and BCLs have since been used for pain relief and pro-
tection in patients with bullous keratopathy, followed by
other indications such as sterile corneal ulcer and kera-
toconjunctivitis sicca [3, 4]. Application of a BCL follow-
ing keratoplasty was first reported in the 1970s to
promote epithelialization, tamponade of small wound
leaks, relief of suture irritation, and smoothing of wound
margin irregularities [5, 6]. Improvements in BCL mater-
ial and technology have enabled the use of high-water-
content BCLs for extended wear [7, 8].
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Despite wide recognition of the usefulness of BCLs for
the postoperative management of corneal transplantation,
no detailed studies of this technique have been reported.
Therefore, we conducted a prospective randomized study
to assess the speed of epithelialization and suppression of




In this randomized, prospective, single-center clinical trial,
we evaluated consecutive patients undergoing corneal trans-
plantation (penetrating keratoplasty [PKP] or deep anterior
lamellar keratoplasty [DALK]) at Tokyo Dental College Ichi-
kawa General Hospital, a referral hospital for corneal trans-
plantation, from October 2006 to May 2008. The protocol
adhered to the principles of the Declaration of Helsinki. The
manuscript reporting adheres to the CONSORT guidelines
for the reporting of randomized trials. Eyes with severe lid/
blink abnormalities, total limbal deficiency, and severe dry
eye with decreased reflex tearing were excluded. Patients
who had diabetes mellitus, those undergone endothelial
keratoplasty or combined intraocular surgeries other than
cataract extraction were also excluded. The patients were
randomly allocated into one of two groups: those who
underwent BCL application at the end of surgery (BCL
group) and those who did not (control group).
Surgical procedure and postoperative treatment
All of the eyes underwent corneal transplantation under
retrobulbar anesthesia with standardized surgical tech-
niques. The donor corneas were preserved in Optisol-GS
corneal storage medium (Bausch & Lomb Inc., Rochester,
NY) and were used for corneal transplantation in < 7 days.
The grafts were trephinated with a 7.75 mm diameter Bar-
ron donor punch (Jedmed Instrument Co., St. Louis, MO),
and recipient corneas were trephinated with a 7.50 mm
diameter Hessburg-Barron vacuum trephine. The donor
grafts were secured by 10–0 nylon sutures with a 24-bite
running suture pattern, or a 16-bite interrupted suture pat-
tern. Suture knots were buried. All surgeries were per-
formed by a single experienced surgeon (J.S.).
A Breath-O® BCL (Toray Industries Inc., Tokyo, Japan),
a hydrophilic lens comprising vinyl pyrrolidone and me-
thyl methacrylate polymer with 78 % water content, was
applied to patients in the BCL group. The lens parameters
were as follows: power plano; base curve, 9.0 mm;
diameter, 13.5 mm; central thickness, 0.22 mm; and oxygen
transmissibility (Dk/L) value, 48 × 10−11 (cm2/s) [mLO2/
(mL•hPa)] (SI). The Japanese Ministry of Health, Labour,
and Welfare approved this contact lens for continuous use
for up to 1 month. BCLs with same parameters were used
in each case.
The eye was patched until the first postoperative day.
All eyes received following standardized postoperative
treatments. They included topical 0.1 % betamethasone
(Rinbeta PF®; Nitten Pharmaceutical Co., Nagoya, Japan)
and 0.5 % levofloxacin (Cravit®; Santen Pharmaceutical
Co., Osaka, Japan) 5 times a day starting 1 day postoper-
atively. No other eye drops were used until epithelializa-
tion was complete. The patients were hospitalized until
complete epithelialization had been achieved (at least
7 days). They were examined every day using slit-lamp
biomicroscopy and fluorescein staining at approximately
the same time of day (around 9:00 a.m.), approximately
1 h later when last eye drops were instilled.
Analysis of pain
A visual analogue scale (VAS) was used to assess the pa-
tients’ pain. The patients responded to a subjective pain
scale before surgery and on postoperative days 1, 3 to 5,
and 7 following corneal transplantation. The VAS is a
10 cm straight line, the ends of which are defined as the ex-
treme limits of the sensation or response to be measured.
The patients marked the position on the scale that indi-
cated their level of ocular pain; the scale ranged from no
pain (score of 0) to worst pain imaginable (score of 100) [9].
Analysis of epithelial defects
The size of the corneal defects was recorded with a co-
balt blue filter following instillation of 2 μL 1 % fluores-
cein solution. The recorded images were analyzed by
ImageJ® software (NIH, Bethesda, MD) using the binary
process. The size of the epithelial defect was calculated
and expressed as that relative to the whole graft area.
The examination was performed at the end of the
surgery and video-recorded under the operating micro-
scope. The epithelial status was also examined with slit-
lamp biomicroscopy on postoperative days 1, 3 to 5, and
7 until total graft healing was achieved. The BCL was re-
moved when epithelialization was complete.
Examinations
A Snellen chart was used for visual acuity testing, and deci-
mal values were converted into their logarithm for statis-
tical analysis. The Schirmer test without topical anesthesia
was performed to evaluate tear secretion. A standardized
strip of filter paper (Alcon Inc., Fort Worth, TX) was placed
in the lateral one-third of the lower lid, and was left in place
for 5 min with the eyes closed. Readings were recorded in
millimeters of wetted paper. Any adverse events possibly
related to the use of the BCL were recorded.
Statistical analysis
GraphPad Prism 6.0 software (GraphPad Software Inc., San
Diego, CA) was used for statistical analysis. The Mann-
Whitney U test and Student’s t-test were used to compare
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nonparametric and parametric values, respectively, be-
tween the two groups. The chi-squared test with Fisher’s
exact test was used for contingence data analysis. A
P value < 0.05 was considered statistically significant.
Results
Patients’ characteristics
In total, 26 eyes of 26 patients were analyzed. There were
14 patients (8 males, 6 females) in the BCL group and 12
patients (5 males, 7 females) in the control group. The
demographic data of the two groups are shown in Table 1.
In the BCL group, causative diseases included bullous ker-
atopathy (n = 7) including one eye with Fuchs’ dystrophy,
regrafting (n = 3), corneal scarring secondary to interstitial
keratitis (n = 2), and keratoconus (n = 2). One eye with ker-
atoconus underwent DALK, and the other 13 eyes under-
went PKP. Seven eyes had combined cataract surgery or
intraocular lens insertion, and four eyes had a history of
glaucoma. In the control group, 11 eyes underwent PKP,
and 1 eye underwent DALK. Causative diseases for corneal
transplantation included regrafting (n = 5, including one
patient who underwent DALK for lattice dystrophy), bul-
lous keratopathy (n = 4), and herpes keratitis (n = 2). Two
eyes underwent combined cataract surgery, and one other
eye had a history of glaucoma. The distribution of causa-
tive diseases in the two groups did not significantly differ
(P = 0.70). There were also no significant differences in
preoperative visual acuity, intraocular pressure, or Schir-
mer test values between the two groups (Table 1).
Effects on pain relief
Changes in the pain scores in both groups are demon-
strated in Fig. 1. The preoperative pain score assessed
using VAS analysis was higher in the BCL group than in
the control group (4.27 ± 1.96 and 2.41 ± 2.18, respectively;
P = 0.039). Both of the groups showed significant increases
in pain scores 1 day postoperatively (16.3 ± 15.2, P = 0.018
and 17.3 ± 13.0, P = 0.0021 in the BCL and control groups,
respectively). However, there were no significant differences
in the postoperative pain scores between the two groups
throughout the study period (P > 0.05). The scores returned
to the preoperative levels by approximately 1 week postop-
eratively in both groups.
Effects on epithelial healing
Epithelial defects in the donor grafts were noted in five
and four eyes in the BCL and control groups, respect-
ively. On postoperative day 1, five eyes in the BCL group
had epithelial defects with a mean percentage area rela-
tive to the whole graft area of 18.2 ± 31.1 % (range, 0.0–
100.0 %). Four eyes in the control group had epithelial
defects with a mean percentage area of 11.5 ± 25.7 %
(range, 0.0–71.0 %). The difference between the two
groups was not statistically significant (P = 0.56). While
three eyes in the BCL group exhibited epithelial defects
on days 3 to 5, no eyes in the control group exhibited
defects (P = 0.10). All of the epithelial defects were com-
pletely epithelialized within 5 and 7 days in the control
and BCL groups, respectively (Fig. 2). The BCLs were
discontinued at a mean of 4.3 days after surgery (range,
2.0–7.0 days). The speed of epithelialization in eyes with
epithelial defects in the control and BCL groups was not
significantly different (Fig. 3).
Adverse events
The BCLs were well tolerated by all of the patients. No
recurrence of epithelial problems was noted following
BCL removal. The BCL was spontaneously dislodged on
postoperative day 3 in one patient; however, epitheliali-
zation was complete on that day, and the BCL was
therefore removed. No other complications were noted,
such as infection, BCL damage, or corneal infiltration.
Discussion
Pain management is important following ocular surgeries,
including corneal transplantation. Postoperative pain may
be caused by various factors such as inflammation, ocular
surface irregularities, exposed suture material, and dam-
aged nerve endings. Pain management includes the use of
acetaminophen, oral nonsteroidal anti-inflammatories,
Table 1 Demographic data in the bandage contact lens (BCL)
and control groups
BCL Control P value
n = 14 n = 12
Age (years) 64.6 ± 15.9 59.1 ± 15.0 0.69
Male: Female 8:6 5:7 0.70
Preoperative visual acuity (log) -1.40 ± 0.91 -1.85 ± 1.36 0.33
Number of previous KPs




(mm per 5 min)
9.71 ± 5.76 12.9 ± 11.7 0.38
Surgery PKP 13 11 1.0
DALK 1 1





Data are expressed as mean ± standard deviation
KPs keratoplasties, PKP penetrating keratoplasty, DALK deep anterior lamellar
keratoplasty, BK bullous keratopathy
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narcotics, pressure patching, and BCL application. In
addition to pain relief, BCLs are used after corneal trans-
plantation for mechanical protection of denuded corneal
epithelium, for maintenance of corneal hydration, as a bar-
rier to the eyelids or lashes, for retention of medication,
and for general promotion of ocular healing [1]. We used
high-water-content soft BCLs in this study, mainly because
these lenses are approved for extended wear.
The severity of postoperative pain differs considerably
from one patient to another. Postoperative pain following
corneal transplantation was reported to be mild by Segev et
al. [10], who used a 4-point verbal pain scale. In their study,
patients reported a mean score of 0.27 on postoperative day
1, corresponding to an approximate score of 8.9 when con-
verted into a full scoring system of 100. Our results showed
slightly higher scores, although they fell within the same
mild pain category. We found no significant differences in
the pain score between eyes with and without BCLs.
Patients in both groups experienced transient increases in
postoperative pain followed by a prompt return to pre-
operative levels (Fig. 1). Because the corneas are in a dener-
vated condition following corneal transplantation, the pain
may be mainly caused by damaged nerve endings, and not
by surface irregularities. Therefore, it is plausible to con-
sider that the application of BCLs has limited value because
its usefulness seems to be exerted through protection of
surface irregularities.
Obtaining stable ocular surface epithelialization is the
first step for success in corneal transplantation. However,
several factors interfere with the achievement of this goal,
including donor- and surgery-related problems such as a
poor donor epithelial status, long preservation time, and
large trephination size [11–14]. Recipient-related factors in-
clude lid problems, decreased tear secretion, poor limbal
function, diabetes mellitus, and the use of various topical

























Fig. 2 Numbers of eyes with epithelial defects in the (a) BCL and (b) control groups. Black column: with epithelial defects; white column: without








Day 0 Day 1 Day 2 Day 3-5 Day 7
Postoperative days
Pain score
Fig. 1 Changes in pain scores assessed using the visual analog scale. BCL group: solid line with square marks; control group: dotted line with circles
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In eyes without wound healing problems, epithelialization
is completed within a median period of 2 days following
corneal transplantation with wide variation [15].
Various approaches to the treatment of epithelial prob-
lems have been reported. Treatment usually starts with
mild intervention including pressure patching, topical lubri-
cants, ointment, and punctual occlusion [11, 14, 16]. Re-
evaluation of topical medications is also important (e.g.,
those containing preservatives such as benzalkonium chlor-
ide may be best to omit from the treatment regimen). If
epithelial defects persist, more aggressive approaches such
as tarsorrhaphy or amniotic membrane patching should be
considered. The application of BCLs is an alternative ap-
proach to promote epithelialization. BCLs provide protec-
tion usually provided by the lids; this protection is needed
to allow migrating epithelial cells to develop proper adher-
ence to the underlying basement membrane, promoting ep-
ithelialization [18]. However, it has also been reported that
the prolonged use of BCLs may be associated with a risk of
infectious keratitis [19].
In this study, no significant differences were found in the
epithelialization speed between eyes with and without BCLs.
One of the reasons for the absence of this effect may be the
relatively healthy donor corneal epithelium; 6 of 14 eyes had
no epithelial defects at the end of surgery. Many of the eyes
with epithelial defects showed mild to moderately sized de-
fects (up to approximately 50 %) 1 day postoperatively. In
another study, 50 of 66 grafts (75.8 %) showed epithelial de-
fects at the end of corneal transplantation with a median
defect size of 20 % [15]. Our results appear to be better than
those in this previous report, presumably because of the dif-
ference in the storage medium used (McCarey-Kaufman
medium vs. Optisol GS). The effects of BCLs on epitheliali-
zation may be obscured when the donor corneal epithelium
is in good condition. Another explanation may be that our
patients had relatively normal tear secretion, blink/lid func-
tion, and limbal function. Wearing BCLs may be advanta-
geous on a more compromised ocular surface. Further
studies in patients at high risk for poor epithelialization are
needed to clarify this point. In addition, the epithelial
surface seemed to be smoother in the BCL groups than in
the control group. The epithelial integrity may be better
with the presence of a BCL. More detailed analysis involving
measurement of the epithelial permeability or confocal
microscopic examination may be necessary.
There were some drawbacks in the present study, such
as the small sample size. It is well known that the fitting
of BCL is influenced by many factors such as condition
of donor/recipient corneas, surgical technique, and postop-
erative treatments. In order to minimize the bias, we only
included cases performed by a single surgeon who used
standardized surgical technique. We also applied the same
postoperative treatments. However, it should be noted that
there were some differences in causative diseases for cor-
neal transplantation between the BCL and control groups,
although the difference in disease distribution did not sig-
nificantly differ. Also, in this prospective study, we included
both eyes with and without epithelial defects at the end of
surgery. Advantages of BCL on epithelial healing may be-
come evident when applied only to the corneas with dam-
aged epithelium. The other drawback was that we used
high water content hydrogel bandage lenses as BCL be-
cause they were the only one that was approved at the time
of initiation of the study. Recently, higher Dk silicone
hydrogel bandage lenses have been replacing the conven-
tional soft contact lenses. The use of more biocompatible
silicone hydrogel-based BCL might lead a positive impact
on the results. We are planning to conduct another study
to examine the efficacy of silicone hydrogel contact lenses
on postkeratoplasty eyes.
Conclusions
The present study failed to show advantages of BCLs on
suppression of postoperative pain or promotion of epitheli-
alization following corneal transplantation. Considering the
cost and additional management associated with the use of
BCLs, we do not recommend using BCLs in all cases. BCLs
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Fig. 3 Percent area of corneal defects relative to graft area in (a) BCL and (b) control groups. Each line represents different eyes
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